The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: A clinical and radiographic analysis

European Spine Journal

Volumn 18, Issue 11, 2009, Pages 1629-1636

  Rihn, Jeffrey A ^a   Makda, Junaid ^a   Hong, Joseph ^a   Patel, Ravi ^b   Hilibrand, Alan S ^a   Anderson, David G ^a   Vaccaro, Alexander R ^a   Albert, Todd J ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Bone morphogenetic protein; Interbody fusion; Lumbar; TLIF; Transforaminal

Indexed keywords

COLLAGEN SPONGE; INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOGRAFT; BONE GRAFT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEMATOMA; HETEROTOPIC OSSIFICATION; HUMAN; LEG PAIN; LOW BACK PAIN; LUMBAR SPINE; MALE; OFF LABEL DRUG USE; OSTEOLYSIS; OSTEOMYELITIS; PATIENT SATISFACTION; PEDICLE SCREW; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICULITIS; RATING SCALE; RETROSPECTIVE STUDY; SEROMA; SPINE FUSION; SPINE RADIOGRAPHY; SPINE SURGERY; TRANSFORAMINAL LUMBAR INTERBODY FUSION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; VERTEBRA BODY; WOUND INFECTION;

BONE MORPHOGENETIC PROTEINS; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 70450245462     PISSN: 09406719     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00586-009-1046-1     Document Type: Article

References (25)

1. SD Boden J Kang H Sandhu, et al. 2002 Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine 27 2662 2673 10.1097/00007632-200212010-00005 10.1097/00007632- 200212010-00005 12461392 (Pubitemid 35425320)
2. JK Burkus JD Dorchak DL Sanders 2003 Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2 Spine 28 372 377 10.1097/00007632-200302150-00012 10.1097/00007632-200302150-00012 12590213 (Pubitemid 36232619)
3. JK Burkus HS Sandhu MF Gornet 2006 Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft Spine 31 775 781 10.1097/01.brs.0000206357.88287.5a 10.1097/01.brs.0000206357.88287.5a 16582851
4. AG Copay SD Glassman BR Subach, et al. 2008 The minimum clinically important difference in lumbar spine surgery patients: a choice of methods using the Oswestry disability index, Medical Outcomes Study questionnaire Short Form 36, and Pain Scales Spine J 8 6 968 974 10.1016/j.spinee.2007.11.006 18201937
5. NE Epstein 2006 A preliminary study of the efficacy of beta tricalcium phosphate as a bone expander for instrumented posterolateral lumbar fusions J Spinal Disord Tech 19 424 429 10.1097/00024720-200608000-00009 10.1097/00024720-200608000-00009 16891978 (Pubitemid 44197594)
6. NE Epstein 2008 An analysis of noninstrumented posterolateral lumbar fusions performed in predominantly geriatric patients using lamina autograft and beta tricalcium phosphate Spine J 8 6 882 887 10.1016/j.spinee.2007.11.005 18280215
7. JC Fernyhough JJ Schimandle MC Weigel, et al. 1992 Chronic donor site pain complicating bone graft harvesting from the posterior iliac crest for spinal fusion Spine 17 1474 1480 10.1097/00007632-199212000-00006 1:STN:280:DyaK3s7htVCmsw%3D%3D 1471005
8. SD Glassman JR Dimar 3rd K Burkus, et al. 2007 The efficacy of rhBMP-2 for posterolateral lumbar fusion in smokers Spine 32 1693 1698 10.1097/BRS.0b013e318074c366 10.1097/BRS.0b013e318074c366 17621221 (Pubitemid 47051857)
9. JA Goulet LE Senunas GL DeSilva, et al. 1997 Autogenous iliac crest bone graft. Complications and functional assessment Clin Orthop Relat Res 1997 76 81 10.1097/00003086-199706000-00011 10.1097/00003086-199706000-00011
10. RW Haid Jr CL Branch Jr JT Alexander, et al. 2004 Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages Spine J 4 527 538 10.1016/j.spinee.2004.03.025 10.1016/j.spinee.2004.03.025 15363423 (discussion 38-39) (Pubitemid 40029169)
11. JG Harms D Jeszenszky 1998 Oper Orthop Traumatol 10 90 102 10.1007/s00064-006-0112-7 10.1007/s00064-006-0112-7 17332991
12. J Harms H Rolinger 1982 A one-stager procedure in operative treatment of spondylolistheses: dorsal traction-reposition and anterior fusion (author's transl) Z Orthop Ihre Grenzgeb 120 343 347 10.1055/s-2008-1051624 10.1055/s-2008-1051624 1:STN:280:DyaL383nvFKrsw%3D%3D 7113376
13. PL Hudak JG Wright 2000 The characteristics of patient satisfaction measures Spine 25 3167 3177 10.1097/00007632-200012150-00012 10.1097/00007632-200012150-00012 1:STN:280:DC%2BD3M7jt1CmtA%3D%3D 11124733 (Pubitemid 32042949)
14. V Joseph YR Rampersaud 2007 Heterotopic bone formation with the use of rhBMP2 in posterior minimal access interbody fusion: a CT analysis Spine 32 2885 2890 10.1097/BRS.0b013e31815b7596 18246013 (Pubitemid 351339361)
15. KU Lewandrowski C Nanson R Calderon 2007 Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases Spine J 7 609 614 10.1016/j.spinee.2007.01.011 10.1016/j.spinee.2007.01.011 17526434 (Pubitemid 47471438)
16. TG Lowe AD Tahernia MF O'Brien, et al. 2002 Unilateral transforaminal posterior lumbar interbody fusion (TLIF): indications, technique, and 2-year results J Spinal Disord Tech 15 31 38 11891448
17. PV Mummaneni J Pan RW Haid, et al. 2004 Contribution of recombinant human bone morphogenetic protein-2 to the rapid creation of interbody fusion when used in transforaminal lumbar interbody fusion: a preliminary report. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004 J Neurosurg Spine 1 19 23 10.3171/spi.2004.1.1. 0019 15291015
18. GL Odom W Finney B Woodhall 1958 Cervical disk lesions J Am Med Assoc 166 23 28 1:STN:280:DyaG1c%2FjsVSmuw%3D%3D 13491305
19. BK Potter BA Freedman EG Verwiebe, et al. 2005 Transforaminal lumbar interbody fusion: clinical and radiographic results and complications in 100 consecutive patients J Spinal Disord Tech 18 4 337 346 10.1097/01.bsd. 0000166642.69189.45 16021015 (Pubitemid 44378151)
20. PD Sawin VC Traynelis AH Menezes 1998 A comparative analysis of fusion rates and donor-site morbidity for autogeneic rib and iliac crest bone grafts in posterior cervical fusions J Neurosurg 88 255 265 10.3171/jns.1998.88.2.0255 1:STN:280:DyaK1c7ht1KisA%3D%3D 9452233
21. JD Schwender LT Holly DP Rouben, et al. 2005 Minimally invasive transforaminal lumbar interbody fusion (TLIF): technical feasibility and initial results J Spinal Disord Tech 18 S1 S6 10.1097/01.bsd.0000132291.50455.d0 10.1097/01.bsd.0000132291.50455.d0 15699793 (Pubitemid 44620794)
22. AT Villavicencio S Burneikiene EL Nelson, et al. 2005 Safety of transforaminal lumbar interbody fusion and intervertebral recombinant human bone morphogenetic protein-2 J Neurosurg Spine 3 436 443 10.3171/spi.2005.3.6.0436 16381205
23. JE Ware Jr RD Hays 1988 Methods for measuring patient satisfaction with specific medical encounters Med Care 26 393 402 10.1097/00005650-198804000-00008 10.1097/00005650-198804000-00008 3352332
24. DA Wong A Kumar S Jatana, et al. 2008 Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2) Spine J 8 6 1011 1018 10.1016/j.spinee. 2007.06.014 18037352
25. K Yamashita K Ohzono K Hiroshima 2006 Patient satisfaction as an outcome measure after surgical treatment for lumbar spinal stenosis: testing the validity and discriminative ability in terms of symptoms and functional status Spine 31 2602 2608 10.1097/01.brs.0000240717.25787.7d 10.1097/01.brs.0000240717. 25787.7d 17047552 (Pubitemid 44632246)